Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring?
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring?
Authors
Keywords
-
Journal
Nature Reviews Gastroenterology & Hepatology
Volume 17, Issue 11, Pages 702-710
Publisher
Springer Science and Business Media LLC
Online
2020-09-02
DOI
10.1038/s41575-020-0352-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Proactive Therapeutic Drug Monitoring of Adalimumab Is Associated With Better Long-term Outcomes Compared With Standard of Care in Patients With Inflammatory Bowel Disease
- (2019) Konstantinos Papamichael et al. Journal of Crohns & Colitis
- DOP56 Dashboard driven vs. conventional dosing of infliximab in inflammatory bowel disease patients: the PRECISION trial
- (2019) A Strik et al. Journal of Crohns & Colitis
- Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases
- (2019) Konstantinos Papamichael et al. Clinical Gastroenterology and Hepatology
- Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn’s Disease
- (2019) Erwin Dreesen et al. Clinical Gastroenterology and Hepatology
- Pharmacokinetics of golimumab in moderate to severe ulcerative colitis: the GO-KINETIC study
- (2019) Sophie E. Berends et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn’s Disease
- (2019) Mark Löwenberg et al. GASTROENTEROLOGY
- Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children with Crohn’s Disease Compared with Reactive Monitoring
- (2019) Amit Assa et al. GASTROENTEROLOGY
- Development and Validation a Magnetic Resonance Index for Assessing Fistulas in Patients With Crohn’s Disease
- (2019) Pieter Hindryckx et al. GASTROENTEROLOGY
- Proactive Infliximab Drug Monitoring Is Superior to Conventional Management in Inflammatory Bowel Disease
- (2019) Samuel Raimundo Fernandes et al. INFLAMMATORY BOWEL DISEASES
- Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study
- (2019) Nicholas A Kennedy et al. Lancet Gastroenterology & Hepatology
- Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2019) Bruce E. Sands et al. NEW ENGLAND JOURNAL OF MEDICINE
- DEVELOPMENT AND VALIDATION OF A TEST TO MONITOR ENDOSCOPIC ACTIVITY IN PATIENTS WITH CROHN’S DISEASE BASED ON SERUM LEVELS OF PROTEINS
- (2019) Geert D’Haens et al. GASTROENTEROLOGY
- Letter: should we intensify infliximab in acute severe ulcerative colitis?
- (2019) David Laharie et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Ustekinumab Pharmacokinetics and Exposure Response in a Phase 3 Randomized Trial of Patients With Ulcerative Colitis
- (2019) Omoniyi J. Adedokun et al. Clinical Gastroenterology and Hepatology
- Systematic review and external validation of prediction models based on symptoms and biomarkers for identifying endoscopic activity in Crohn's disease
- (2019) Eelco C. Brand et al. Clinical Gastroenterology and Hepatology
- Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease: a multicentre prospective observational study
- (2018) W. Yacoub et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Subcutaneous rather than intravenous ustekinumab induction is associated with comparable circulating drug levels and early clinical response: a pilot study
- (2018) C. R. Rowan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Mucosal Healing and Long-term Outcomes of Patients With Inflammatory Bowel Diseases Receiving Clinic-Based vs Trough Concentration-Based Dosing of Infliximab
- (2018) Lieven Pouillon et al. Clinical Gastroenterology and Hepatology
- Clinical Pharmacokinetics and Pharmacodynamics of Infliximab in the Treatment of Inflammatory Bowel Disease
- (2018) Amy Hemperly et al. CLINICAL PHARMACOKINETICS
- Maintenance Adalimumab Concentrations Are Associated with Biochemical, Endoscopic, and Histologic Remission in Inflammatory Bowel Disease
- (2018) Anna Juncadella et al. DIGESTIVE DISEASES AND SCIENCES
- Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease
- (2018) Omoniyi J. Adedokun et al. GASTROENTEROLOGY
- Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn’s Disease
- (2018) Geert D’Haens et al. GASTROENTEROLOGY
- Accelerated Infliximab Dosing Increases 30-Day Colectomy in Hospitalized Ulcerative Colitis Patients: A Propensity Score Analysis
- (2018) Shailja C Shah et al. INFLAMMATORY BOWEL DISEASES
- Therapeutic Drug Monitoring With Ustekinumab and Vedolizumab in Inflammatory Bowel Disease
- (2018) Sophie Restellini et al. INFLAMMATORY BOWEL DISEASES
- Proactive Therapeutic Drug Monitoring of TNF Antagonists in Inflammatory Bowel Disease
- (2018) Xavier Roblin et al. INFLAMMATORY BOWEL DISEASES
- Therapeutic Drug Monitoring of Biologics for Inflammatory Bowel Disease: An Answer to Optimized Treatment?
- (2018) Hannah Hoseyni et al. JOURNAL OF CLINICAL PHARMACOLOGY
- DOP046 Higher serum concentrations of vedolizumab are associated with superior endoscopic outcomes in Crohn’s disease: data from the LOVE-CD trial
- (2018) S Berends et al. Journal of Crohns & Colitis
- Comparative Accuracy of Bowel Ultrasound Versus Magnetic Resonance Enterography in Combination With Colonoscopy in Assessing Crohn’s Disease and Guiding Clinical Decision-making
- (2018) Mariangela Allocca et al. Journal of Crohns & Colitis
- Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study
- (2018) Mariangela Allocca et al. Journal of Crohns & Colitis
- Predictors of relapse following infliximab de-escalation in patients with inflammatory bowel disease: the value of a strategy based on therapeutic drug monitoring
- (2018) Camille Lucidarme et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Infliximab Exposure-Response Relationship and Thresholds Associated with Endoscopic Healing in Patients With Ulcerative Colitis
- (2018) Niels Vande Casteele et al. Clinical Gastroenterology and Hepatology
- Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients
- (2018) María Chaparro et al. DIGESTIVE DISEASES AND SCIENCES
- Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn’s Disease
- (2018) Paul Rutgeerts et al. GASTROENTEROLOGY
- American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease
- (2017) Joseph D. Feuerstein et al. GASTROENTEROLOGY
- Advances in Use of Endoscopy, Radiology, and Biomarkers to Monitor Inflammatory Bowel Diseases
- (2017) Julian Panes et al. GASTROENTEROLOGY
- Clinical relevance of detecting anti-infliximab antibodies with a drug-tolerant assay: post hoc analysis of the TAXIT trial
- (2017) Thomas Van Stappen et al. GUT
- Exposure–efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn’s Disease
- (2017) Maria Rosario et al. Journal of Crohns & Colitis
- European Crohn’s and Colitis Organisation Topical Review on Treatment Withdrawal [‘Exit Strategies’] in Inflammatory Bowel Disease
- (2017) Glen Doherty et al. Journal of Crohns & Colitis
- Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial
- (2017) Jean-Frederic Colombel et al. LANCET
- Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
- (2017) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic factors for long-term infliximab treatment in Crohn's disease patients: a 20-year single centre experience
- (2016) T. Billiet et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis
- (2016) B. Ungar et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis
- (2016) Shailja C. Shah et al. Clinical Gastroenterology and Hepatology
- Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases
- (2016) Bella Ungar et al. Clinical Gastroenterology and Hepatology
- Pharmacokinetic Features and Presence of Antidrug Antibodies Associate With Response to Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis
- (2016) Johannan F. Brandse et al. Clinical Gastroenterology and Hepatology
- Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future
- (2016) Daniela Pugliese et al. Expert Review of Clinical Immunology
- Optimizing Treatment with TNF Inhibitors in Inflammatory Bowel Disease by Monitoring Drug Levels and Antidrug Antibodies
- (2016) Casper Steenholdt et al. INFLAMMATORY BOWEL DISEASES
- Higher Adalimumab Levels Are Associated with Histologic and Endoscopic Remission in Patients with Crohnʼs Disease and Ulcerative Colitis
- (2016) Andres J. Yarur et al. INFLAMMATORY BOWEL DISEASES
- Systematic Review and Meta-Analysis: Serum Infliximab Levels During Maintenance Therapy and Outcomes in Inflammatory Bowel Disease
- (2016) Clare Moore et al. Journal of Crohns & Colitis
- Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
- (2016) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adalimumab trough serum levels and anti-adalimumab antibodies in the long-term clinical outcome of patients with Crohn’s disease
- (2016) Giorgia Bodini et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Loss of Response to Anti-TNFs: Definition, Epidemiology and Management
- (2016) Giulia Roda et al. Clinical and Translational Gastroenterology
- Systematic review: predicting and optimising response to anti-TNF therapy in Crohn's disease - algorithm for practical management
- (2015) N. S. Ding et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- C-Reactive Protein, Fecal Calprotectin and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis
- (2015) Mahmoud H Mosli et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
- (2015) L Peyrin-Biroulet et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis
- (2015) Maria Theresa Arias et al. Clinical Gastroenterology and Hepatology
- Concentrations of 6-Thioguanine Nucleotide Correlate With Trough Levels of Infliximab in Patients With Inflammatory Bowel Disease on Combination Therapy
- (2015) Andres J. Yarur et al. Clinical Gastroenterology and Hepatology
- Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab
- (2015) Henit Yanai et al. Clinical Gastroenterology and Hepatology
- An Accelerated Infliximab Induction Regimen Reduces the Need for Early Colectomy in Patients With Acute Severe Ulcerative Colitis
- (2015) David J. Gibson et al. Clinical Gastroenterology and Hepatology
- Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
- (2015) Niels Vande Casteele et al. GASTROENTEROLOGY
- The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS study
- (2015) Andres J Yarur et al. GUT
- Disease Activity Assessment in IBD
- (2015) James D. Falvey et al. INFLAMMATORY BOWEL DISEASES
- Crohn's disease management after intestinal resection: a randomised trial
- (2015) Peter De Cruz et al. LANCET
- Adalimumab dose escalation is effective for managing secondary loss of response in Crohn's disease
- (2014) C. Ma et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review with network meta-analysis: the efficacy of anti-tumour necrosis factor-alpha agents for the treatment of ulcerative colitis
- (2014) R. W. Stidham et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Association Between Serum Concentration of Infliximab and Efficacy in Adult Patients With Ulcerative Colitis
- (2014) Omoniyi J. Adedokun et al. GASTROENTEROLOGY
- Tumor Necrosis Factor-Alpha Antagonists Twenty Years Later
- (2014) Anthony A. Akobeng et al. INFLAMMATORY BOWEL DISEASES
- Bowel Perfusion Measured with Dynamic Contrast-enhanced Ultrasound Predicts Treatment Outcome in Patients with Crohnʼs Disease
- (2014) Fredrik Saevik et al. INFLAMMATORY BOWEL DISEASES
- Usefulness of abdominal ultrasonography in the analysis of endoscopic activity in patients with Crohn's disease: Changes following treatment with immunomodulators and/or anti-TNF antibodies
- (2014) Nadia Moreno et al. Journal of Crohns & Colitis
- Subcutaneous ustekinumab for the treatment of anti-TNF resistant Crohn's disease—The McGill experience
- (2014) U. Kopylov et al. Journal of Crohns & Colitis
- Adalimumab for Crohn's disease: Long-term sustained benefit in a population-based cohort of 438 patients
- (2014) Charlotte P. Peters et al. Journal of Crohns & Colitis
- Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy
- (2014) Rita Monterubbianesi et al. Journal of Crohns & Colitis
- Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: a multicenter experience
- (2013) D. Laharie et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Long-term Outcome of Perianal Fistulizing Crohn's Disease Treated With Infliximab
- (2013) Guillaume Bouguen et al. Clinical Gastroenterology and Hepatology
- Association Between Pharmacokinetics of Adalimumab and Mucosal Healing in Patients With Inflammatory Bowel Diseases
- (2013) Xavier Roblin et al. Clinical Gastroenterology and Hepatology
- Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Accuracy of Magnetic Resonance Enterography in Assessing Response to Therapy and Mucosal Healing in Patients With Crohn's Disease
- (2013) Ingrid Ordás et al. GASTROENTEROLOGY
- Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial
- (2013) Casper Steenholdt et al. GUT
- 52-Week Efficacy of Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis Who Failed Corticosteroids and/or Immunosuppressants
- (2013) Walter Reinisch et al. INFLAMMATORY BOWEL DISEASES
- Noninvasive Diagnosis of Small Bowel Crohn’s Disease
- (2013) Fabiana Castiglione et al. INFLAMMATORY BOWEL DISEASES
- Therapeutic Drug Monitoring of Infliximab and Mucosal Healing in Inflammatory Bowel Disease
- (2013) Stephane Paul et al. INFLAMMATORY BOWEL DISEASES
- Addition of Thiopurines Can Recapture Response in Patients with Crohn's Disease who Have Lost Response to Anti-Tnf Monotherapy
- (2013) David EH Ong et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
- (2013) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFα blocking agents
- (2012) Pauliina Molander et al. INFLAMMATORY BOWEL DISEASES
- Mucosal Healing in Crohnʼs Disease
- (2012) Peter De Cruz et al. INFLAMMATORY BOWEL DISEASES
- Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's disease
- (2012) Martin Bortlik et al. Journal of Crohns & Colitis
- Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease
- (2011) J. Panés et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
- (2011) Alexander C Ford et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2011) William J. Sandborn et al. GASTROENTEROLOGY
- Efficacy, tolerability, and predictors of response to infliximab therapy for Crohn's disease: A large single centre experience
- (2011) Michael B. Sprakes et al. Journal of Crohns & Colitis
- Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis
- (2011) M. De Vos et al. Journal of Crohns & Colitis
- Randomised clinical trial: certolizumab pegol for fistulas in Crohn’s disease - subgroup results from a placebo-controlled study
- (2010) S. Schreiber et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose and How to Predict Response?
- (2010) Geert R D'Haens et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Monitoring functional serum antitumor necrosis factor antibody level in Crohnʼs disease patients who maintained and those who lost response to anti-TNF
- (2010) Akihiro Yamada et al. INFLAMMATORY BOWEL DISEASES
- Endoscopic monitoring of infliximab therapy in Crohnʼs disease
- (2010) Clas-Göran af Björkesten et al. INFLAMMATORY BOWEL DISEASES
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abdominal Sonographic Changes After Antibody to Tumor Necrosis Factor (Anti-TNF) Alpha Therapy in Crohn’s Disease
- (2009) José María Paredes et al. DIGESTIVE DISEASES AND SCIENCES
- Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease
- (2009) Filip Baert et al. GASTROENTEROLOGY
- Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis
- (2009) C H Seow et al. GUT
- Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials
- (2008) Laurent Peyrin–Biroulet et al. Clinical Gastroenterology and Hepatology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started